These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2539680)

  • 1. The natural history of obliterative bronchiolitis and occlusive vascular disease of patients following heart-lung transplantation.
    Scott JP; Higenbottam TW; Clelland C; Hutter JA; Stewart S; Otulana BA; Wallwork J
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2592-3. PubMed ID: 2539680
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
    Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
    J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
    Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J
    J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
    Valentine VG; Robbins RC; Berry GJ; Patel HR; Reichenspurner H; Reitz BA; Theodore J
    J Heart Lung Transplant; 1996 Apr; 15(4):371-83. PubMed ID: 8732596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for chronic rejection in heart and lungs--why do hearts and lungs rot?
    Wallwork J
    Clin Transplant; 1994 Jun; 8(3 Pt 2):341-4. PubMed ID: 8061378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic rejection in single-lung transplantation manifested by obliterative bronchiolitis.
    LoCicero J; Robinson PG; Fisher M
    J Thorac Cardiovasc Surg; 1990 Jun; 99(6):1059-62. PubMed ID: 2359323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
    Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of pediatric lung and heart-lung transplantation.
    Kurland G; Orenstein DM
    Curr Opin Pediatr; 1994 Jun; 6(3):262-71. PubMed ID: 8061735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation.
    Woodrow JP; Shlobin OA; Barnett SD; Burton N; Nathan SD
    J Heart Lung Transplant; 2010 Oct; 29(10):1159-64. PubMed ID: 20580267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart-lung transplantation, single lung and both lungs].
    Héritier F; Rochat T
    Schweiz Rundsch Med Prax; 1993 May; 82(19):581-2. PubMed ID: 8506439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances and perspectives of heart-lung transplantation].
    Harringer W; Haverich A
    Z Kardiol; 2000; 89 Suppl 7():85-90. PubMed ID: 11098564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of graft vascular disease after heart and heart-lung transplantation and its relationship to obliterative bronchiolitis.
    Billingham ME
    Transplant Proc; 1995 Jun; 27(3):2013-6. PubMed ID: 7792870
    [No Abstract]   [Full Text] [Related]  

  • 13. [Post-lung transplantation bronchiolitis obliterans].
    Fournier M; Groussard O; Mal H; Sleiman C; Duchatelle JP; Andreassian B; Pariente R
    Rev Mal Respir; 1995; 12(1):5-11. PubMed ID: 7899668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.
    Dusmet M; Maurer J; Winton T; Kesten S
    J Heart Lung Transplant; 1996 Sep; 15(9):948-54. PubMed ID: 8889991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.
    Cooper JD; Billingham M; Egan T; Hertz MI; Higenbottam T; Lynch J; Mauer J; Paradis I; Patterson GA; Smith C
    J Heart Lung Transplant; 1993; 12(5):713-6. PubMed ID: 8241207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.
    Reichenspurner H; Girgis RE; Robbins RC; Yun KL; Nitschke M; Berry GJ; Morris RE; Theodore J; Reitz BA
    Ann Thorac Surg; 1996 Nov; 62(5):1467-72; discussion 1472-3. PubMed ID: 8893585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.
    Davis RD; Lau CL; Eubanks S; Messier RH; Hadjiliadis D; Steele MP; Palmer SM
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):533-42. PubMed ID: 12658195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies.
    Starnes VA; Theodore J; Oyer PE; Billingham ME; Sibley RK; Berry G; Shumway NE; Stinson EB
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 1):683-90. PubMed ID: 2554067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
    Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.